Literature DB >> 3386820

Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy.

O Hardiman1, T Burke, J Phillips, S Murphy, B O'Moore, H Staunton, M A Farrell.   

Abstract

Fifty patients underwent superficial temporal lobectomy for intractable temporal lobe epilepsy. Total cure rate was 52%, and significant improvement was achieved in 88%. Cytoarchitectural changes in gray and white tissue were analyzed under light microscopy. Neuronal dysgenesis was correlated with the duration of seizure disorder, age of onset, and other etiologic factors, and with clinical outcome. Temporal lobes from 33 neurologically normal autopsy brains which were age- and sex-matched with patients were examined as controls. Severe neuronal ectopia (greater than 8 neurons/2 mm2 white matter) was present in 42% of patients with epilepsy and in none of controls. There was neuronal clustering in 28% of those with epilepsy, and Chaslin's (subpial) gliosis in 38%. Controls did not have these changes. The presence of severe neuronal ectopia and clustering was predictive of a favorable clinical outcome following surgery (p less than 0.05). No correlation was found between microdysgenesis and other factors. These findings suggest that the presence of neuronal dysgenesis may be of significance in the clinical outcome following surgery, and that the abnormal tissue may be important as a morphologic substrate for seizures in some patients.

Entities:  

Mesh:

Year:  1988        PMID: 3386820     DOI: 10.1212/wnl.38.7.1041

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Epilepsy and Cortical Dysplasias.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

2.  Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study.

Authors:  M J De Rosa; D L Secor; M Barsom; R S Fisher; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Focal cortical dysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy.

Authors:  Nadia Colombo; Laura Tassi; Carlo Galli; Alberto Citterio; Giorgio Lo Russo; Giuseppe Scialfa; Roberto Spreafico
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

4.  Febrile Seizures and Mesial Temporal Sclerosis.

Authors:  Shlomo Shinnar
Journal:  Epilepsy Curr       Date:  2003-07       Impact factor: 7.500

Review 5.  Early history of subplate and interstitial neurons: from Theodor Meynert (1867) to the discovery of the subplate zone (1974).

Authors:  Miloš Judaš; Goran Sedmak; Mihovil Pletikos
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

6.  Surgical outcome and prognostic factors of pediatric epilepsy caused by cortical dysplasia.

Authors:  Chul-Kee Park; Seung-Ki Kim; Kyu-Chang Wang; Yong-Seung Hwang; Ki Joong Kim; Jong Hee Chae; Je G Chi; Ghee-Young Choe; Na Rae Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2006-03-16       Impact factor: 1.475

7.  Lesional mesial temporal lobe epilepsy and limited resections: prognostic factors and outcome.

Authors:  H Clusmann; T Kral; E Fackeldey; I Blümcke; C Helmstaedter; J von Oertzen; H Urbach; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 8.  Neurodevelopmental liabilities in epilepsy.

Authors:  Antonio Gil-Nagel
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy.

Authors:  Beril Gok; George Jallo; Reza Hayeri; Richard Wahl; Nafi Aygun
Journal:  Neuroradiology       Date:  2012-12-08       Impact factor: 2.804

10.  Callosotomy for intractable epilepsy from bihemispheric cortical dysplasias.

Authors:  R Pallini; S Aglioti; G Tassinari; G Berlucchi; C Colosimo; G F Rossi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.